BACKGROUND: Sleep disturbance may affect smoking cessation efforts. We describe sleep changes across three months among women in a smoking cessation program and tested whether sleep disturbances at baseline and 1 month post-quit attempt predicted smoking status at three months. METHODS:Participants (N=322) were women in a randomized, clinical trial for smoking cessation. Sleep disturbances, as well as, insomnia, drowsiness, and sleep quality were evaluated prior to and during three months of cessation treatment. Repeated measures mixed models evaluated change in sleep over time by smoking outcome status. Logistic regression analyses determined whether sleep disturbances at baseline and 1 month post-quit were associated with smoking status at 3 months. RESULTS:Sleep disturbances were reported by more than 25% of women. Drowsiness, insomnia, and sleep quality changed over time. However, contrary to our hypotheses, none of the sleep variables at either baseline or 1 month post-quit attempt was associated with relapse (p's>.05). CONCLUSIONS: Although mild to severe drowsiness was reported by more women who relapsed than those who remained abstinent, none of the sleep disturbance symptoms predicted smoking relapse. Given high rates of sleep disturbances among women smokers, better prospective evaluations of the relationship of sleep disturbances to smoking cessation treatment outcome are needed.
RCT Entities:
BACKGROUND:Sleep disturbance may affect smoking cessation efforts. We describe sleep changes across three months among women in a smoking cessation program and tested whether sleep disturbances at baseline and 1 month post-quit attempt predicted smoking status at three months. METHODS:Participants (N=322) were women in a randomized, clinical trial for smoking cessation. Sleep disturbances, as well as, insomnia, drowsiness, and sleep quality were evaluated prior to and during three months of cessation treatment. Repeated measures mixed models evaluated change in sleep over time by smoking outcome status. Logistic regression analyses determined whether sleep disturbances at baseline and 1 month post-quit were associated with smoking status at 3 months. RESULTS:Sleep disturbances were reported by more than 25% of women. Drowsiness, insomnia, and sleep quality changed over time. However, contrary to our hypotheses, none of the sleep variables at either baseline or 1 month post-quit attempt was associated with relapse (p's>.05). CONCLUSIONS: Although mild to severe drowsiness was reported by more women who relapsed than those who remained abstinent, none of the sleep disturbance symptoms predicted smoking relapse. Given high rates of sleep disturbances among women smokers, better prospective evaluations of the relationship of sleep disturbances to smoking cessation treatment outcome are needed.
Authors: D E Jorenby; S J Leischow; M A Nides; S I Rennard; J A Johnston; A R Hughes; S S Smith; M L Muramoto; D M Daughton; K Doan; M C Fiore; T B Baker Journal: N Engl J Med Date: 1999-03-04 Impact factor: 91.245
Authors: D E Jorenby; D K Hatsukami; S S Smith; M C Fiore; S Allen; J Jensen; T B Baker Journal: Psychopharmacology (Berl) Date: 1996-11 Impact factor: 4.530
Authors: Afroditi K Boutou; Eleni A Tsiata; Athanasia Pataka; Paschalina K Kontou; Georgia G Pitsiou; Paraskevi Argyropoulou Journal: Prim Care Respir J Date: 2008-03
Authors: Christi S Ulmer; Hayden B Bosworth; Anne Germain; Jennifer Lindquist; Maren Olsen; Mira Brancu; Jean C Beckham Journal: J Behav Med Date: 2015-03-27
Authors: Michael A Grandner; Natasha J Williams; Kristen L Knutson; Dorothy Roberts; Girardin Jean-Louis Journal: Sleep Med Date: 2015-02-28 Impact factor: 3.492
Authors: Nicole A Short; Brittany M Mathes; Brittany Gibby; Mary E Oglesby; Michael J Zvolensky; Norman B Schmidt Journal: Addict Res Theory Date: 2016-06-29
Authors: Anka A Vujanovic; Samantha G Farris; Christopher B Harte; Jasper A J Smits; Michael J Zvolensky Journal: Ment Health Phys Act Date: 2013-06-01